Pioneering in molecular cancer diagnostics, Ipsogen develops and markets worldwide a full range of diagnosis assays targeting most molecular anomalies known in leukaemia , including the most rare forms of the disease.

We have written this section, to enable you to better understand how our tests guide oncologists' and their patients' decision at each step of the disease.